Scientific Writing and Project Management in Biotechnology

Scientific Writing Techniques and Project Management in Biotechnology has been designed to provide a comprehensive basic text for medical and biotechnology students to make them conversant with molecular biology techniques, bioinformatics, art of planning and writing scientific research, issues of ethics and funding that arise while doing a research. In the past decades, the power of genetic analysis has grown with the introduction of recombinant DNA technology and genomics. Acquiring DNA sequence has become a routine Deciphering genetic information encoded in DNA sequence requires knowledge of what to look for, algorithms capable of detecting interesting features in sequences and computers to perform such complex analysis, leading to emergence of the new field of bioinformatics. Molecular biology is driven to a great extent by economics and a future researcher biotechnologist needs to be conversant with patenting issues biotech project management and product life cycle and capital investment and marketing, leading to emergence of a specialized subject biotechnology entrepreneurship. The book has separate sections on survey of techniques in molecular biology research and development of projects management of projects and marketing of biotechnology inventions and intellectual property and patenting.

Chapter 2 Price: 2.99

Human Genomic Project deciphered 3 billion base pairs that make up the genetic
code. In 1988, US National Research Council’s special committee formulated a 15-years
human genome project, costing some $ 200 million a year. In September 1994, a genetic
map with 1 cM resolution was accomplished and a physical map involving 52,000 sequence-
tagged sites (STSs) was completed in October 1998.

Chapter 3 Price: 2.99

It is the science of using information to understand biology. It is conceptualizing
biology in terms of molecules and applying informatics techniques (computer science,
applied mathematics and statistics) to organize the information associated with these
molecules. Bioinformatics and data mining are two latest areas of research involving
computer-assisted management of data generated for biotechnology applications. The information
generated in genomics is enormous and its interpretation requires the use of powerful
computers and specific softwares.

Chapter 4 Price: 2.99

What is a Scientific Paper
A scientific paper is not
a technical report or term paper. It is a paper worth writing
only if it has general implications for knowledge. One should think of his role as guiding
future efforts of scholars since others will come after you with newer data and better
models!

Chapter 6 Price: 2.99

Chapter
F
UNDING
A
GENCIES
SCIENCE FUNDING ORGANIZA
TIONS
Biotechnology companies e
specially those profitable today, face a coming decade that
may be even painful than the past decade was for global pharma, when many saw their
valuations cut in half, not to mention all restructuring and management havoc. Most
biotech companies achieved their success behind just one or two block busting drugs that
are priced boldly and marketed aggressively. In spite of billions in R and D, large pharma
have failed to produce much in the way of next round of innovations. It seems increasingly
clear that once a biotechnology company reaches a certain size, it, like its large pharma
counterparts, becomes unable to get much out of its heavy R&D spending.

Chapter 8 Price: 2.99

“Biological resource centres
BRCs
are an essential part of the infrastructure underpinning
life sciences and biotechnology. They consist of service providers and repositories of the
living cells, genomes of organism, and information relating to heredity and the functions
of biological systems. BRCs contain collections of culturable organisms (e.g.,
micro-organisms,
plant, animal and human cells), replicable parts of these (e.g.,
genomes, plasmids, viruses,
cDNAs), viable but not yet culturable organisms, cells and tissues, as well as databases
containing molecular, physiological and structural information relevant to these collections
and related bioinformatics”

Chapter 9 Price: 2.99

Biotechnology has unlimited potential due to its capability to generate unlimited
range of and useful products/services concerned with virtually every aspect of human
existence. e.g., in mid-90s, over 130 biotechnologically derived pharmaceuticals aimed at
everything from hemophilia to AIDS, and from anaemia to leukaemia, were under regulatory
review in USA. The contribution of biotechnological products to global market is rising
rapidly and is expected to increase from US $ 100 billion/year in 2000 to further higher.

Chapter 10 Price: 2.99

The key survival of pharmaceutical and biotechnology companies is to place successful
products on the market place. Project managers are becoming an increasingly integral
part of that strategy.
Biotechnology and pharmaceutical companies face constant challenges in the course
of developing new pharmaceuticals or other products.

Chapter 11 Price: 2.99

IP arises from an a
pplication of intellect and ingenuity and is usually in the form of
an idea, concept, design, process etc. to generate a product ultimately. With emergence
of modern technology, intellectual property is legal characterization and treatment of
trade-related biotechnological processes and products